2026年10月12日

How to Sell Cosmetics in Australia

Quick Answer: To sell cosmetics in Australia, first determine whether the product is a cosmetic or a therapeutic good. For commercial cosmetic imports, address AICIS business registration and ingredient-introduction requirements, review Australian ingredient labels, and establish product safety and supplier documentation. Overseas approval does not replace Australian compliance. Allocate the importer, brand and manufacturer tasks before ordering stock, rather than treating one factory certificate as a market-access passport.

MOOYAM editorial content. Last reviewed: 12 October 2026. Cover: AI-generated editorial illustration.

What is the Australian cosmetic compliance pathway?

Australian market entry is a set of connected decisions, not a single cosmetic registration certificate. A beauty brand must align its product category, formulation, retail presentation and supply arrangement. A compliant project brief should therefore describe the exact product being launched, the Australian business handling it and the evidence supporting release.

This guide is an overview for brand owners, importers and distributors. It separates regulatory requirements from suggested project controls. It does not determine the legal status of a particular formula or replace qualified product-specific advice. Use the global cosmetic registration overview to understand why different markets require different steps.

Three different regulatory questions to resolve
AreaRelevant authorityQuestion for the brand
Cosmetic or therapeutic goodTGA classification guidanceWhat do the ingredients, intended use and claims mean for this product?
Industrial chemical introductionAICISWho introduces the ingredients into Australia, and what pathway applies?
Ingredient information and product safetyACCC / Product SafetyDoes the Australian retail presentation meet applicable requirements?

First, is the product a cosmetic or a therapeutic good?

The Therapeutic Goods Act 1989, section 3 (official PDF) defines therapeutic goods with reference to therapeutic use, including how goods are represented or likely to be taken to be used. Review applicable exclusions and product-specific circumstances as well. Writing “beauty product” on the pack does not settle the legal classification.

As a practical control, prepare one approved claims sheet covering the label, online store, advertising and distributor copy. Keep it beside the formula version and instructions for use. If a proposed statement promises treatment or changes how the product acts, ask the reviewer to reconsider classification before committing to artwork. Sun-protection and other boundary products deserve particular care; this overview does not classify an individual sunscreen.

Do not assume that a distributor’s product category on an e-commerce platform is a regulatory decision. Ask who reviewed the actual product and what information that review covered. If classification remains unresolved, hold the launch decision while obtaining the missing advice.

Who needs to address AICIS registration?

The Industrial Chemicals Act 2019, sections 12–13 (official PDF) requires an industrial chemical introducer to be registered for the relevant registration year before introduction. Assess whether your cosmetic supply arrangement involves an introduction covered by the Act, including its scope and exclusions. This is an introducer-registration obligation, not a finished-product approval certificate.

Section 24 requires introductions to be authorised under an applicable category. Sections 25–30 address listed, exempted, reported, assessed, commercial evaluation and exceptional-circumstances introductions. Reporting and record-keeping provisions also apply. Confirm the detailed pathway, applicable rules and deadlines before introduction; registration alone does not complete this review.

For project management, name the introducing business explicitly. Agree who obtains technical information, who submits any required information and who monitors ongoing obligations. A sourcing contract that merely says “supplier responsible for compliance” leaves practical questions unanswered. It may also fail to reflect the Australian parties’ actual statutory roles.

What formulation information should the importer request?

Start with a controlled formula and a clear route for confidential technical disclosure. Ask the supplier to identify the ingredients used in the actual production version and provide the information your reviewer needs. Do not invent missing identities, concentrations or manufacturing descriptions to fill a submission field.

Suggested technical handover inputs, not a universal statutory submission list
InputWhat to checkWorking purpose
Formula-linked ingredient informationIdentity, relevant composition data and version controlSupport the Australian ingredient review
Relevant COA and SDSMaterial or batch, issuing supplier, revision and scopeTechnical and quality handover
Stability and microbiological informationWhether the evidence covers the proposed formula and useSupport product-specific safety decisions
Packaging compatibility and specificationsActual pack materials, closure and finished configurationCheck the proposed retail product
Manufacturing and batch documentationTraceability, release checks and agreed change noticesManage production and post-launch investigation

These records do not all have the same legal status. A laboratory report is evidence with a defined scope, not an automatic Australian market authorisation. A supplier’s document checklist is likewise not an official regulator checklist. Let a competent reviewer decide which evidence is appropriate to the product and pathway.

If the factory supplies a pre-existing stock formula, confirm that the samples, labels and production order refer to that same version. A change in fragrance, preservative or packaging should not disappear inside a purchasing email. Record what changed and ask whether the earlier review and test evidence remain applicable.

What does ingredient labelling require?

The Consumer Goods (Cosmetics) Information Standard 2020, section 7 requires ingredient lists on the container or, where there is no container, on the product. Where size, shape or nature prevents these methods, another method must ensure the consumer can be informed about the ingredients. Check the instrument’s application and exclusions before applying this summary.

The standard permits an ingredient-order option with non-colour ingredients at 1% or more in descending order by volume or mass, followed by those below 1% in any order and then colour additives in any order. Review the full standard, its scope and any relevant exceptions rather than applying this summary to every possible product.

Artwork review should be a distinct release step. Compare the final printed pack with the approved composition and the actual retail setup. Check readability at production size, not only in an enlarged PDF. Keep the reviewer-approved print proof and make sure the packaging supplier receives that exact file. Review other applicable product, claims and consumer-information rules separately; ingredient labelling is not the whole compliance assessment.

What does the manufacturer provide, and what does the brand provide?

Recommended project coordination; statutory responsibilities require separate assessment
Physical OEM/ODM manufacturerBrand and Australian importerJoint release decision
Controlled formula, pack and production inputsIntended use, market scope and complete claims briefConfirm what product is actually being assessed
Agreed test and quality documentationArrange Australian classification and ingredient reviewClose missing evidence before ordering stock
Manufacturing, batch and change-control recordsArrange registration, relevant reporting and local compliance administrationIdentify owners and escalation contacts
Packaging specifications and approved sampleApprove Australian retail artwork and customer-facing copyRelease the exact formula and pack combination

A manufacturer can support the technical handover without becoming the Australian importer. Conversely, a brand’s marketing approval does not demonstrate that an ingredient-introduction review was completed. Treat commercial service commitments and legal responsibilities as separate questions, and document both.

For sourcing considerations rather than legal classification, see working with a cosmetic manufacturer for Australian brands. Keep a named person responsible for collecting outstanding evidence instead of assuming the sales contact and technical reviewer share the same task list.

A practical six-step launch checklist

  1. Define the product: freeze the formula version, intended use, pack and proposed claims.
  2. Resolve classification: obtain a product-specific decision or advice where the cosmetic/therapeutic boundary is uncertain.
  3. Confirm the introducing party: arrange the relevant AICIS review and administration before the affected introduction.
  4. Close documentation gaps: match supplier records to the product; do not replace missing evidence with assumptions.
  5. Release the retail presentation: review artwork and point-of-sale information against applicable requirements.
  6. Maintain controls: retain relevant records, monitor required reporting and route complaints or changes to the responsible people.

Use a release sheet with three clear outcomes: complete, not applicable with an explanation, or unresolved. An empty cell is not approval. Preserve the basis for decisions so a later team member can understand why the product was released and which conditions were attached.

Common mistakes that delay an Australian launch

  • Treating overseas approval as a passport: Australian requirements still need their own review.
  • Reviewing the formula but ignoring advertising: inconsistent claims can change the classification question.
  • Using evidence for another product: check formula, pack, batch and report scope before relying on it.
  • Ordering printed packaging before technical sign-off: keep artwork changes possible until the required decisions are closed.
  • Forgetting post-launch ownership: agree who handles records, regulatory correspondence and complaints.

FAQ

Do I register my cosmetic product or my business with AICIS?

AICIS registration is for the introducing business. It does not replace the review of relevant chemical introductions.

Does a cosmetic already sold overseas automatically qualify for Australia?

No. Assess the Australian pathway, retail presentation and supply arrangement independently.

Do all cosmetics need TGA approval?

No. Classification determines whether therapeutic-goods regulation applies; do not make a decision solely from a product’s beauty branding.

Can the OEM factory complete every Australian obligation?

Do not assume so. Confirm the factory’s agreed services, the actual introducing party and the responsibilities that apply locally.

How long does cosmetic market entry take?

There is no universal project duration. Classification questions, missing formulation information, the applicable pathway and artwork changes affect the schedule.

Is a GMP certificate enough to release a product?

No. Supplier quality evidence and Australian market-entry requirements answer different questions.

Plan your Australian OEM/ODM handover

MOOYAM provides cosmetic OEM/ODM manufacturing and technical documentation support for international beauty brands. Discuss your formula, packaging and evidence needs through our OEM/ODM service or contact team. Australian regulatory conclusions should be checked with the relevant authority or qualified professional.

Regulatory requirements may change. Brands should verify current requirements with the relevant regulatory authority or qualified compliance professional before placing cosmetic products on the market.

WhatsApp 8615813510569